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The alkaloids of Banisteriopsis 
caapi, the plant source of 
the Amazonian hallucinogen 
Ayahuasca, stimulate adult 
neurogenesis in vitro
Jose A. Morales-García  1,2,3, Mario de la Fuente Revenga  4,5,8, Sandra Alonso-Gil1,2,  
María Isabel Rodríguez-Franco5, Amanda Feilding6, Ana Perez-Castillo1,2 & Jordi Riba4,7
Banisteriopsis caapi is the basic ingredient of ayahuasca, a psychotropic plant tea used in the Amazon 
for ritual and medicinal purposes, and by interested individuals worldwide. Animal studies and recent 
clinical research suggests that B. caapi preparations show antidepressant activity, a therapeutic effect 
that has been linked to hippocampal neurogenesis. Here we report that harmine, tetrahydroharmine 
and harmaline, the three main alkaloids present in B. caapi, and the harmine metabolite harmol, 
stimulate adult neurogenesis in vitro. In neurospheres prepared from progenitor cells obtained from 
the subventricular and the subgranular zones of adult mice brains, all compounds stimulated neural 
stem cell proliferation, migration, and differentiation into adult neurons. These findings suggest that 
modulation of brain plasticity could be a major contribution to the antidepressant effects of ayahuasca. 
They also expand the potential application of B. caapi alkaloids to other brain disorders that may 
benefit from stimulation of endogenous neural precursor niches.
Ayahuasca is the Quechua name used to designate Banisteriopsis caapi, a jungle liana of the Malpighiaceae family 
that is native to the Amazon and Orinoco river basins1. The term is also applied to the tea that is obtained by 
infusing in water the stems of B. caapi, alone or in combination with other plants2. The ayahuasca tea is a central 
element in the ancient shamanic practices and rites of passage of the indigenous inhabitants of northwestern 
South America. More recently, ayahuasca has become a central sacrament in the rituals of Brazilian syncretic reli-
gious groups. These so-called “ayahuasca religions” have popularized ayahuasca use with the expansion of their 
activities to North America and Europe3.
Ayahuasca has a complex chemistry and pharmacology. B. caapi contains high amounts of harmine and tet-
rahydroharmine (THH) and to a lesser degree harmaline, three indole alkaloids with β-carboline structure4. 
These alkaloids are reversible monoamine-oxidase-A (MAO-A) inhibitors5, while THH can also inhibit serotonin 
reuptake6. Although B. caapi can be the sole ingredient of the tea7, up to 100 different plants have been described 
as admixtures to ayahuasca. These plants contain a wide variety of psychotropic substances such as nicotine 
(from Nicotiana spp.), scopolamine (from Brugmansia spp.), caffeine (from Ilex guayusa and Paullinia yoco), 
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cocaine (from Erythoxylum coca) and N,N-dimethyltryptamine (DMT, from Psychotria viridis and Diplopterys 
cabrerana)2, 8.
In recent years, non-traditional use of ayahuasca has expanded worldwide, especially the version of the tea 
that combines B. caapi with P. viridis, due to the visionary effects induced by DMT, a psychedelic serotonin-2A 
agonist9. This expansion and reports of health benefits derived from its use have stimulated research into the 
pharmacology and therapeutic potential of ayahuasca10. Two recent studies found that a single dose of ayahuasca 
rapidly reduced depressive symptoms in treatment-resistant patients11, 12. Remarkably, clinical improvement was 
maintained for up to three weeks. With the resurgence of research on psychedelics13, the β-carbolines of B. caapi 
have been considered to play a minor role in the overall pharmacology of ayahuasca preparations. However, this 
is probably a narrow view. B. caapi is the common ingredient to all ayahuasca brews, and chemical analyses have 
shown that while the β-carbolines are present in all ayahuasca samples, this is not always the case for DMT14, 15. 
For instance, an ayahuasca sample from the Brazilian Church União do Vegetal, a group known to regularly com-
bine B. caapi with P. viridis in their ayahuasca, was found to contain no DMT at all16.
Due to their ubiquitous presence in ayahuasca, it can be hypothesized that the β-carbolines contribute to the 
CNS effects of the tea. Studies in animals have shown that harmine has antidepressant effects in behavioral animal 
models of depression17, 18. Responses after harmine in the forced swim and open field tests are analogous to those 
obtained with ayahuasca infusions prepared from B. caapi and P. viridis and containing DMT19, 20. These findings 
suggest that DMT is not essential for the behavioral responses observed in animals. Additionally, in contrast 
with more traditional antidepressants such as imipramine, harmine increases BDNF levels in the hippocam-
pus after both acute and chronic administration18, 21. These data suggest that harmine and potentially the other 
β-carbolines present in B. caapi contribute to the therapeutic effects of ayahuasca observed in clinical studies 
involving patients with depression11, 12.
At the cellular level, antidepressant drug action has been linked to the ability of drugs to stimulate adult 
neurogenesis22. Neurogenesis is the process of generating functional neurons from progenitor cells. In the adult 
brain of mammals, neurogenesis occurs in two main niches: the subventricular zone (SVZ) of the lateral ventricle 
and the subgranular zone of the dentate gyrus of the hippocampus (SGZ). Neural stem cells in these areas can be 
induced to asymmetrically divide, generating new stem cells, and astrocytes, oligodendrocytes or neurons23, 24. 
These newly generated neurons have the capacity to migrate and integrate into existing neural circuits. The activ-
ity and phenotypic fate of neural stem cells is determined by both endogenous and exogenous factors25. Beyond 
understanding the mechanisms of adult neurogenesis, we are ultimately interested in its therapeutic capacity. 
Specifically, despite their various mechanism of action, clinically-effective antidepressants share the common 
feature of inducing neural stem cell proliferation and differentiation into new neurons26–28.
Here, we investigated the capacity of the three main β-carbolines present in B. caapi to induce neurogenesis 
in vitro using neural progenitor cells from adult mice. We decided to focus on the alkaloids found in all aya-
huasca brews, rather than on nicotine, DMT, scopolamine or other psychoactive compounds that can be present 
in ayahuasca following the addition of the admixture plants mentioned above. To this end neurospheres were 
prepared from stem cells obtained from both the SVZ and the SGZ and treated with harmine, THH, harmaline, 
and harmol. The latter is present only in small amounts in B. caapi but is readily formed in vivo in humans via 
O-demethylation of harmine, which undergoes extensive first-pass metabolism4, 29, 30. As shown below, results 
showed that the B. caapi β-carboline alkaloids present in ayahuasca directly regulate proliferation, migration and 
differentiation of neural stem cells.
Results
B. caapi β-carbolines control the activity of neural progenitors. We isolated neural stem cells from 
the SVZ and the SGZ and we cultured them as free-floating neurospheres. Neurospheres from adult tissue are 
characterized by self-renewal and multipotent differentiation. To study the “stemness” of cultured neurospheres, 
we analyzed the expression of the following proteins: (a) musashi-1, a marker of undifferentiation; (b) nestin, 
an intermediate filament protein characteristic of neural stem/progenitor cells; and (c) “sex determining region 
Y-box 2” (SOX-2), a transcription factor essential for maintaining self-renewal and pluripotency of undifferenti-
ated stem cells. We treated the neurosphere cultures for 7 days under proliferative conditions with each of the four 
β-carbolines: harmol, harmine, harmaline and tetrahydroharmine, all at 1 µM concentration. After treatment, we 
isolated the proteins and performed Western blots. Figure 1 clearly shows significant reductions in the amount of 
musashi-1, nestin and SOX-2 in the SVZ (musashi: F(4,15) = 49.87, p < 0.001; nestin: F(4,15) = 50.105, p < 0.001; 
SOX-2: F(4,15) = 121.684, p < 0.001) and SGZ (musashi: F(4,15) = 32.819, p < 0.001; nestin: F(4,15) = 141.556, 
p < 0.001; SOX-2: F(4,15) = 22.572, p < 0.001) neurospheres following treatment with the test compounds. These 
results indicated that the β-carbolines promote a loss of “stemness” or undifferentiated state of the neurospheres.
B. caapi β-carbolines induce proliferation and growth in neurosphere cultures. We analyzed next 
whether the treatment with test compounds modulated proliferation capacity in the neurosphere. For this pur-
pose, we grew free floating neurospheres under proliferative conditions, i.e., in the presence of epidermal growth 
factor (EFG) and fibroblast growth factor (FGF) for 7 days, with the addition of saline (control) or each of the 
four tested β-carbolines. As shown in Fig. 2, addition of the alkaloids to the cultures markedly increased the rate 
of formation and the size of the neurospheres.
After 7 days of β-carboline treatment, the number of SVZ-derived neurospheres was significantly higher 
than in the vehicle-treated cultures (F(4,15) = 466.512, p < 0.001). Analogous results were observed for neuros-
pheres derived from the SGZ (F(4,15) = 1226.445, p < 0.001). Regarding the size of the neurospheres, significant 
increases were observed for both SVZ- and SGZ-derived neurospheres after β-carboline treatment, as compared 
with non-treated cultures (SVZ: F(4,15) = 126.858, p < 0.001); SGZ: F(4,15) = 172.617, p < 0.001). In view of 
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Figure 1. Effects of ayahuasca β-carboline alkaloids on stemness of cultured adult neurospheres. Representative 
Western blots and bar graphs showing expression levels of the precursor cell markers musashi-1, nestin and 
SOX-2 after treatment with each of the four alkaloids tested (1 µM). Values in bar graphs indicate mean ± SD of 
the quantification of at least three independent experiments corresponding to four different cellular pools. The 
left side of the image shows results for the subventricular zone (SVZ) of the brain. The right side of the image 
shows results for the subgranular zone of the hippocampus (SGZ). *p ≤ 0.05; **P ≤ 0.01; ***p ≤ 0.001 indicate 
significant results in the post-hoc pair-wise comparisons (Bonferroni) versus non-treated (basal) cultures.
www.nature.com/scientificreports/
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Figure 2. Effects of ayahuasca β-carboline alkaloids on adult neurosphere formation. (a) Representative phase-
contrast micrographs showing the number and size of neurospheres after 7 days in culture in the presence of 
each of the four alkaloids tested (1 µM). The number and diameter of at least 50 neurospheres was determined 
in control and treated cultures. Scale bar = 100 μm. (b) Bar graphs showing results as mean values ± SD of the 
quantification of at least three independent experiments corresponding to four different cellular pools. The 
left side of the image shows results for the subventricular zone (SVZ) of the brain. The right side of the image 
shows results for he subgranular zone of the hippocampus (SGZ). *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001 indicate 
significant results in the post-hoc pair-wise comparisons (Bonferroni) versus non-treated (basal) cultures.
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Figure 3. Effects of ayahuasca β-carboline alkaloids on adult neural stem cells proliferation. (a) Representative 
immunofluorescence images showing the expression of the cellular marker for proliferation ki67 (green) in 
neurospheres derived from the subventricular zone (SVZ) of the lateral ventricle and the subgranular zone 
(SGZ) of the hippocampus. SVZ-derived neurospheres are shown in two panels showing the central part of the 
sphere (left) and the distal migration site (right). Single images from SGZ-derived neurospheres show the whole 
neurosphere, including the central and distal areas. DAPI was used for nuclear staining. Scale bar = 50 μm. (b) 
Representative Western blots of ki67 and the proliferating cell nuclear antigen (PCNA) levels in neurospheres 
treated for 7 days with each of the four alkaloids tested (1 µM). Bar graphs show the results of the quantification 
analyses. Each bar indicates relative protein levels expressed as mean ± SD of the quantification of at least three 
independent experiments corresponding to four different cellular pools. The left side of the image shows results 
for the subventricular zone (SVZ) of the brain. The right side of the image shows results for he subgranular 
zone of the hippocampus (SGZ). *p ≤ 0.05; **p ≤ 0.01 indicate significant results in the post-hoc pair-wise 
comparisons (Bonferroni) versus non-treated (basal) cultures.
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these results, we next analyzed the expression of Ki67, a marker of dividing cells, and “proliferating cell nuclear 
antigen” (PCNA) (Fig. 3).
As expected, treatment of the cultures with the β-carbolines resulted in an increase in the number of 
Ki67- (SVZ: F(4,15) = 514.405, p < 0.001); SGZ: F(4,15) = 51.976, p < 0.001) and PCNA-positive cells (SVZ: 
F(4,15) = 7.905, p < 0.001); SGZ: F(4,15) = 42.213, p < 0.001), indicating a direct effect of these compounds on 
proliferation. These results indicated that the β-carbolines actively stimulate the proliferation and growth of neu-
rospheres from both the SVZ and the SGZ by controlling the activity of neural progenitors.
B. caapi β-carbolines increase neural stem cell migration. In addition to proliferation and differen-
tiation, neurogenesis involves the migration of neural stem cells and their integration into functional circuits. We 
thus tested next the effects of the β-carbolines on precursor migration. We treated the neurospheres with each of 
the test compounds and we monitored migration of the newly formed cells using livescanning microscopy for 
48–72 h. The results are presented in Supplementary Figure 1 (and in the Supporting Information Videos 1–5). 
As shown therein, β-carboline treatment resulted in significant increases in migration capacity (SVZ: 
F(4,15) = 349.872, p < 0.001); SGZ: F(4,15) = 1203.666, p < 0.001) in comparison with basal (control). Neural 
stem cells moved long distances out of the neurosphere body in the presence of the four tested compounds. On 
the contrary, cells in the control cultures remained close to the neurosphere core.
B. caapi β-carbolines induce differentiation of neural stem cells. We investigated the capacity of the 
β-carbolines to promote cell differentiation into any of the three different cellular types that form the central nerv-
ous system: astrocytes, neurons and/or oligondendrocytes. We analyzed the formation of the different cell types 
using immunocytochemistry. Neurosphere cultures prepared from the SVZ and the SGZ were adhered to a sub-
strate and cultured under differentiation conditions, that is, in the absence of growth factors and in the presence 
of 1% fetal bovine serum. The β-carbolines were added to the medium and, after 3 days in culture, we evaluated 
the expression of Tuj1- and MAP-2-positive cells by immunocytochemistry analysis (Fig. 4a) and we quantified 
these proteins by Western blot (Fig. 4b). After the three-day period, vehicle-treated cultures only showed a few 
positively-stained cells for Tuj-1 or MAP-2. On the contrary, in the β-carboline-treated cultures, the number of 
both Tuj1- (SVZ: F(4,15) = 16.295, p < 0.001); SGZ: F(4,15) = 45.997, p < 0.001) and MAP-2-positive cells (SVZ: 
F(4,15) = 41.631, p < 0.001); SGZ: F(4,15) = 22.951, p < 0.001) was significantly increased. These results indicate 
that the test compounds induce the differentiation of neural stem cells towards mature neurons.
Concerning the formation of astrocytes or oligodendrocytes, Fig. 5 shows that most of the test compounds did 
not induce the differentiation of neural precursors towards an oligondedrocyte phenotype. Results showed that 
only the harmol- and harmaline-treated SVZ cultures presented some scattered CNPase-positive cells (Fig. 5a). 
These results were further confirmed by quantification of the Western blots (Fig. 5b; SVZ: F(4,15) = 7.853, 
p < 0.001); SGZ: F(4,15) = 1.472, p > 0.05)). In the case of GFAP-positive cells, a high number was observed 
in basal conditions (Fig. 5) and this number was increased after β-carboline treatment (SVZ: F(4,15) = 43.838, 
p < 0.001); SGZ: F(4,15) = 136.268, p < 0.001), suggesting that these compounds also promote the differentiation 
of astroglial cells or astrocyte-like radial cells.
Discussion
Here we showed that adult neural stem cell activity is regulated by harmine, THH, and harmaline, the most abun-
dant alkaloids in B. caapi and ayahuasca, and by harmol, the main metabolite of harmine in humans31. Using an in 
vitro model of adult neurogenesis, we found that all four β-carbolines stimulated the proliferation and migration 
of progenitor cells and promoted their differentiation predominantly into neurons.
The four compounds tested effectively promoted proliferation, migration, and differentiation of progenitor 
cells obtained from the SVZ and the SGZ, the two main niches of adult neurogenesis in rodents. The β-carbolines 
increased the number and size of primary neurospheres, induced the loss of the neurospheres’ undifferentiated 
state, and promoted subsequent cell migration and differentiation mainly into a neuronal phenotype, as indicated 
by the positive expression of β-III-tubulin and MAP2, but also into astroglial cells. Taken together, these three 
effects indicate that B. caapi alkaloids have the capacity to regulate the expansion and fate of stem cell populations.
Analysis of the proliferation stage showed that all four β-carbolines increased the number and size of neu-
rospheres, the number of Ki-67-stained cells, and the amounts of Ki-67 and PCNA protein as measured by 
Western blot. Our results for the effect of harmine on proliferation are in line with a previous study showing 
harmine-induced increase in mitosis in cultured chick embryo cells32, and in human neural progenitor cells33. To 
our knowledge, the effects of harmaline and THH on neurogenesis have not been studied before. While harma-
line is only present in small amounts in B. caapi, THH is the second most abundant β-carboline in the plant4, 29. 
Additionally, THH shows more consistent plasma levels between individuals and studies than harmine, which is 
rapidly degraded to harmol when taken orally29, 34. The latter, formed in vivo by O-demethylation of the parent 
compound29, showed proliferative effects of similar magnitude to those of harmine.
Our results showed that B. caapi β-carbolines promoted cellular migration and differentiation, suggesting that 
these alkaloids not only act as mitogens for neural stem cells, but also modulate cellular fate. The largest effects 
on migration were observed for harmaline and THH. Increased migration capacity is relevant in certain condi-
tions such as brain injury, where stem cell niches are far from the damaged area35–37. All tested compounds also 
promoted cellular differentiation. Neural stem cells are known to differentiate into neurons, astrocytes, and oli-
godendrocytes23, 24. The observed increases in Tuj-1 and MAP-2 protein expression indicated differentiation pre-
dominantly toward a neuronal phenotype. In the SVZ both proteins were equally expressed after each of the four 
treatments. However, in the SGZ harmine administration did not influence Tuj-1 levels, a marker of immature 
neurons, but significantly increased the expression of MAP-2, suggesting a larger impact on neuronal maturation.
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Figure 4. Ayahuasca β-carboline alkaloids promote stem cell differentiation towards a neuronal phenotype. 
After 7 days on culture in the presence of harmol, harmine, harmaline and tetrahydroharmine (THH), 
free floating neurospheres derived from the adult subgranular (SGZ) and subventricular (SVZ) zone were 
adhered on coated coverslips and allowed to differentiate for 3 days in the presence of alkaloids at 1 µM. (a) 
Representative immunofluorescence images showing the expression of the neuronal markers β-III-Tubulin 
(TuJ-1 clone, green) and MAP-2 (red) in neurospheres. DAPI was used for nuclear staining. SVZ-derived 
neurospheres are shown in two panels showing the central part of the sphere (left) and the distal migration 
site (right). Single images from SGZ-derived neurospheres show the whole neurosphere, including the central 
and distal areas. Scale bar = 50 μm. (b) Representative Western blots of β-tubulin and MAP-2. Quantification 
analyses are also shown. Results are the mean ± SD of the quantification of at least three independent 
experiments corresponding to four different cellular pools. The left side of the image shows results for the 
subventricular zone (SVZ) of the brain. The right side of the image shows results for he subgranular zone of the 
hippocampus (SGZ). *p ≤ 0.05; **p ≤ 0.01 indicate significant results in the post-hoc pair-wise comparisons 
(Bonferroni) versus non-treated (basal) cultures.
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Figure 5. Ayahuasca β-carboline alkaloids promote astrogliogenesis. Neurospheres derived from the adult 
subgranular (SGZ) and subventricular (SVZ) zone were cultured in the presence of harmol, harmine, harmaline 
and tetrahydroharmine (THH). After 7 days neurospheres were adhered on coated coverslips and allowed 
to differentiate for 3 days in the presence of alkaloids at 1 µM. (a) Neurosphere immunofluorescence images 
showing in green the expression of CNPase (oligodendrocyte marker) and glial fibrillary acidic protein (GFAP, 
red) that stains astrocytes. SVZ-derived neurospheres are shown in two panels showing the central part of the 
neurosphere (left) and the distal migration site (right). Single images from SGZ-derived neurospheres show 
the distal part of the neurosphere. DAPI was used for nuclear staining. Scale bar = 50 μm. (b) Representative 
Western blots of CNPase and GFAP. Quantification analyses are also shown. Results are the mean ± SD of the 
quantification of at least three independent experiments corresponding to four different cellular pools. The left 
side of the image shows results for the subventricular zone (SVZ) of the brain. The right side of the image shows 
results for he subgranular zone of the hippocampus (SGZ). *p ≤ 0.05; **p ≤ 0.01 indicate significant results in 
the post-hoc pair-wise comparisons (Bonferroni) versus non-treated (basal) cultures.
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All the above indicate that B. caapi β-carbolines facilitate neurogenesis at multiple levels. This capacity is of 
interest, since in pathological conditions the replacement of neurons may be optimized by acting simultane-
ously on various processes38, 39. The effect of the β-carbolines on cellular proliferation and differentiation is not 
unique to these compounds, having been observed for endogenous molecules such as leukotriene B440, BMPs41, 
the growth factors EGF/FGF242, and NGF/BDNF/bFGF43, and the transcription factors Lmx1a and Lmx1b44. 
However, the fact that the β-carbolines also stimulated migration highlights the versatility of these exogenous 
compounds, as they can promote the three processes involved in full adult neurogenesis.
A likely possible explanation for the observed effects of β-carbolines in neurogenesis is the increase in mon-
oamine levels caused by MAO inhibition. With this said, we must acknowledge that the magnitude of the neu-
rogenic effects was similar for the four compounds, despite harmol and THH being inhibitors that are between 
a hundred and a thousand times weaker than harmine or harmaline5. Moreover, the role of monoamines in neu-
rogenesis is not fully understood. Knocking out the 5-HT1A receptor in mice impaired neurogenesis after fluox-
etine but not after imipramine, indicating that neurogenesis was independent from elevated serotonin levels45. 
In another study, the authors reported the unexpected finding that serotonin depletion actually promoted 
hippocampal neurogenesis instead of decreasing it46. In a recent paper, harmine, but not the MAO inhibitor 
pargyline, stimulated proliferation of human neural progenitor cells in vitro33. Harmine effects were mediated 
through inhibition of the DYRK1A kinase rather than through MAO inhibition. This opens the possibility that 
the β-carbolines tested here regulated stem cell fate via DYRK1A or other alternative mechanisms. To our knowl-
edge, the inhibitory effects of harmaline, tetrahydroharmine and harmol on DYRK1A has not been examined. 
Other potential molecular targets for the neurogenic effects of small molecules include the modulation of the 
GSK-3β/β-catenin pathway 47, upregulation of the brain-derived neurotrophic factor48, increased levels of vascu-
lar endothelial growth factor49; and glucocorticoid receptor activation50. Future studies should assess whether B. 
caapi β-carbolines interact with one or more of these pathways.
Our findings have relevant therapeutic implications. The association between neurogenesis and 
anti-depressant activity is well documented45, 51. Enhanced hippocampal neurogenesis reduces depression-like 
behaviors in animals51. Furthermore, clinically effective antidepressants stimulate neurogenesis, independent of 
their chemical structure and mechanism of action. To cite a few examples, chronic treatment with the serotonin 
reuptake inhibitor fluoxetine increases neurogenesis in rats52, 53, as does chronic treatment with the selective 
MAO-A inhibitor pirlindole53. The association between neurogenesis and antidepressant effect is not limited to 
rodents and pharmacological interventions. Electroconvulsive therapy in primates also stimulates proliferation 
of neural precursors in the hippocampus and their differentiation into neurons54. Hippocampal neurogenesis 
appears to be necessary for antidepressant action. Irradiation of the SGZ of the hippocampus in mice prevents the 
neurogenic and behavioral effects of fluoxetine and imipramine45.
In humans, two recent clinical studies have demonstrated rapid and long-lasting antidepressant effects after a 
single ayahuasca dose in patients who did not respond to conventional treatment11, 12. The therapeutic potential 
of ayahuasca is an area of increasing research interest beyond depression55. Alterations in adult neurogenic niches 
have been associated with a number of pathologies affecting the central nervous system56–59. Stimulation of these 
niches is currently being investigated as a novel therapeutic strategy for neuropsychiatric disorders60–62. Regular 
ayahuasca use has been associated decreases in problematic alcohol, cocaine and opiate consumption, indicating 
anti-addiction properties for B. caapi preparations63, 64. These potential anti-addictive properties are particularly 
relevant if we acknowledge the notorious difficulty of treating substance use disorders. Drug-dependent patients 
not only show functional deficits in reward processing and cognitive control, but also structural alterations in 
brain gray and white matter65.
Our study has a series of limitations that need to be acknowledged. Ayahuasca brews contain other active 
compounds that were not tested here. A popular version of ayahuasca in the USA and Europe contains DMT, a 
serotonergic psychedelic9. It is possible that DMT may have contributed to the antidepressant effects reported in 
clinical studies using ayahuasca11, 12. This contribution could be due to both brain plasticity mediated by 5-HT2A 
receptor activation66 and to the profound psychological experiences induced by psychedelics67. While studying 
DMT in the neurogenesis model was not an objective of the present investigation, it could be assessed in a future 
study, comparing it with other 5-HT2A agonists such as psilocybin or LSD. Although several animal studies have 
already shown that harmine improves behavioral measures of depression17, 18, future studies could ideally test the 
four compounds assessed here for both in vivo neurogenesis and behavioral improvement. Finally, future research 
could also use positive controls to compare the potency of the B. caapi β-carbolines with that of other antidepres-
sants, such as SSRIs and MAO inhibitors.
In conclusion, here we showed that the β-carboline alkaloids present in B. caapi, the plant source of the aya-
huasca tea, promote neurogenesis in vitro by stimulating neural progenitor pool expansion, and by inducing 
cellular migration and differentiation into a neuronal phenotype. The stimulation of neurogenic niches in the 
adult brain may substantially contribute to the antidepressant effects reported for ayahuasca in recent clinical 
studies. The versatility and full neurogenic capacity of the B. caapi β-carbolines warrant further investigation of 
these compounds. Their ability to modulate brain plasticity indicates their therapeutic potential for a broad range 
of psychiatric and neurologic disorders.
Methods
Ethics. Animals used in this study were cared for following the animal experimental procedures previously 
approved by the “Ethics Committee for Animal Experimentation” of the Instituto de Investigaciones Biomédicas 
and carried out in accordance with the European Communities Council, directive 2010/63/EEC and National 
regulations, normative 53/2013.
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Drugs. Harmine and harmaline were obtained from commercial sources (Sigma-Aldrich). Harmol and tet-
rahydroharmine were obtained by synthesis following the procedures described below.
Synthesis of harmol and tetrahydroharmine. 1-Methyl-9H-pyrido[3,4-b]indol-7-ol hydrobromide (har-
mol·HBr). To a solution of harmine (151 mg, 0.71 mmol, Sigma-Aldrich) in acetic acid (3 mL) hydrobromic 
acid (3 mL, 47% aqueous solution) was added. The mixture was heated at 160 °C during 25 min in a microwave 
oven and then allowed to cool to room temperature. After few minutes at 25 °C, needles started to form and 
harmol·HBr·H2O (180 mg, 85% yield) was recovered by filtration as a yellow solid of mp 250–251 °C. 1H NMR 
(400 MHz, D2O) δ 7.62 (d, J = 5.4 Hz, 1 H), 7.39 (d, J = 5.4 Hz, 1 H), 7.18 (d, J = 8.4 Hz, 1 H), 6.26 (d, J = 8.5 Hz, 
1 H), 5.96 (s, 1 H), 2.31 (s, 3 H). 13C NMR (101 MHz, D2O) δ 158.55, 143.69, 134.75, 132.07, 131.27, 127.49, 122.97, 
112.87, 112.18, 111.48, 95.12, 14.77. HPLC purity 100% (230 to 400 nm). HRMS (ESI+): m/z calcd for C12H10N2O: 
198.07931, found: 198.07934. Anal. Calcd for C12H10N2O·HBr·H2O (297.15): C, 48.50; H, 4.41; N, 9.43. Found: C 
48.08; H 4.29; N 9.52.
7-Methoxy-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole hydrochloride (tetrahy-droharmine·HCl, 
THH·HCl). Sodium borohydride (680 mg, 18.00 mmol) was added in portions to a stirred solution of harma-
line (1.54 g, 7.20 mmol, Sigma-Aldrich) in water (40 mL) at 0 °C and the mixture was acidified until pH 2 with 
aqueous HCl (2 M). After 75 min at room temperature, the mixture was made alkaline with NaOH (10% aqueous 
solution), extracted with dichloromethane (3 × 20 mL) and evaporated to dryness. Solid was dissolved in iso-
propyl alcohol, heated and then treated with an excess of concentrated HCl until a precipitate appeared. After 3 
days at 4 °C, THH·HCl was collected by filtration (1.40 g, 77% yield) as a white solid of mp 201–202 °C. 1H NMR 
(400 MHz, DMSO) δ 10.98 (s, 1 H), 7.34 (d, J = 8.6 Hz, 1 H), 6.85 (d, J = 2.2 Hz, 1 H), 6.68 (dd, J = 8.6, 2.2 Hz, 1 H), 
4.68 (q, J = 6.8 Hz, 1 H), 3.76 (s, 3 H), 3.59 (dt, J = 12.4, 4.7 Hz, 1 H), 3.37–3.27 (m, 1 H), 2.97–2.81 (m, 2 H), 1.59 
(d, J = 6.7 Hz, 3 H). 13C NMR (101 MHz, DMSO) δ 155.93, 136.95, 129.62, 120.17, 118.75, 108.97, 105.14, 94.67, 
55.19, 48.42, 40.40, 18.30, 17.24. HPLC purity 98% (230 to 400 nm). Anal. Calcd for C13H16N2O·HCl (252.74): C, 
61.78; H, 6.78; N, 11.08. Found: C 61.46; H 6.86; N 10.84.
Adult precursor isolation. Neural stem cells (NSCs) were isolated from the subgranular zone (SGZ) of the 
hippocampus and the subventricular zone (SVZ) of the lateral ventricle of adult C57BL/6 mice (3 months of age) 
and prepared following previously described methods68. A total number of 40 animals were used throughout 
the whole study, divided in four pools of 10 animals each. Every pool was individually used to perform all the 
experiments described in this section. Briefly, tissue was carefully dissected, dissociated in DMEM medium with 
glutamine, gentamicin and fungizone and then digested with 0.1% trypsin-EDTA + 0.1% DNAase + 0.01% hia-
luronidase for 15 min at 37 °C. The isolated stem cells were seeded into 12-well dishes at a density of ~40,000 cells 
per cm2 in DMEM/F12 (1:1) containing 10 ng/mL epidermal growth factor (EGF), 10 ng/mL fibroblast growth 
factor (FGF) and N2 medium.
Neurosphere cultures and treatments. NSCs were cultured under standard conditions and in 
the presence of growth factors (EGF and FGF) for a week, in 12-well dishes. After this time, small neural 
progenitor-enriched growing spheres known as neurospheres (NS) were formed. At this point, with all NS hav-
ing the same stage and size, cultures were treated daily for 7 days with vehicle or 1 μM solutions of each of the 
four β-carbolines tested: harmol, harmine, harmaline and tetrahydroharmine (THH). The effective dose of com-
pounds was chosen based on our previous studies on β-carboline analogs69 and the 7-day period was selected as 
a standard time frame used previously by our own and other research groups to test the neurogenic potential of 
drugs37, 50, 68, 70. The 1 μM concentrations chosen for the β-carbolines was lower than the 7.5 μM found to induce 
optimal proliferation in a previous in vitro study with harmine33 but closer to the plasma concentrations of 0.52–
1.52 μM reported for harmine and THH, respectively, in a recent study involving ayahuasca administration to 
healthy humans71. At these concentrations, none of the tested β-carbolines affected the viability of the cultured 
cells. Proliferation and growth analysis was assessed from these cultures and the number and diameter of NS 
were quantified using the Nikon Digital Sight, SD-L1 software. All the NS contained in ten wells per condition 
were counted. Some of these proliferating NS were used for immunoblotting analysis, while others were seeded 
onto poly-L-lysine precoated-6-well plates, and/or -coverslips and cultured in the presence of β-carboline alka-
loids (1 μM) under proliferation conditions (medium containing 1% fetal bovine serum and without exogenous 
growth factors). Once neurospheres were differentiated (72 h), those grown on coated 6-well plates were used for 
immunoblotting and those on coverslips for immunocytochemical analysis. The remaining NS were cultured for 
48–72 h under differentiation conditions onto μ-Slide 8-well plates (Ibidi, Martinsried, Germany) and used for 
migration assays.
Immunocytochemistry. Cells were processed for immunocytochemistry as previously described69. Briefly, 
NS grown on glass were previously fixed 15 minutes at room temperature in 4% paraformaldehyde and incu-
bated at 37 °C for 1 h with primary antibodies directed against ki67 (1/200, rabbit, Abcam), β-III-tubulin (1/400, 
TuJ-1 clone; rabbit; Abcam), MAP-2 (1/200, mouse; Sigma), CNPase (rabbit, Covance) and GFAP (1/500, mouse; 
Sigma). After several rinses in PBS, samples were then incubated with Alexa-488 goat anti-rabbit and Alexa-
647 goat anti-mouse antibodies (1/500, Molecular Probes) for 45 min at 37 °C. Staining of nuclei was performed 
using 4′,6-diamidino-2-phenylindole (DAPI, 1/500). Finally images were acquired in a LSM710 laser scanning 
spectral confocal microscope (Zeiss). Confocal microscope settings were adjusted to produce the optimum 
signal-to-noise ratio.
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Immunoblot analysis. Differentiated cultured NS were re-suspended in ice-cold cell lysis buffer (Cell 
Signaling Technology) with protease inhibitor cocktail (Roche) and incubated for 15–30 min on ice. A total 
amount of 30 µg of protein was loaded on a 10% or 12% SDS-PAGE gel and transferred to nitrocellulose mem-
branes (Protran, Whatman). The membranes were blocked in Tris-buffered saline with 0.05% Tween-20 and 
5% skimmed milk or 4% BSA (MAP-2 blots), incubated with primary and secondary antibodies, and washed 
according to standard procedures. Primary antibodies used were: musashi-1 (1/500, rabbit; Abcam), nestin 
(1/500, rabbit; Abcam), SOX-2 (1/1000, mouse, Cell Signaling), ki67 (1/500, rabbit, Abcam), PCNA (1/500, 
mouse, Millipore), β-III-tubulin (1/1000, TuJ clone; mouse; Covance), MAP-2 (1/500, mouse; Sigma), CNPase 
(1/500, rabbit, Covance), GFAP (1/1000, mouse; Sigma) and α-tubulin (1/5000, mouse; Sigma). Secondary 
peroxidase-conjugated (1/1000) donkey anti-rabbit (Amersham Biosciences, GE Healthcare), or rabbit 
anti-mouse antibodies (Jackson Immunoresearch) were used. Values in figures are the average of the quantifica-
tion of at least three independent experiments each of them corresponding to four different cellular pools.
Cellular migration assay. Free-floating single spheres were individually picked up with a pipette and plated 
onto μ-Slide 8-well plates as previously described70. Images were acquired with a Cell Observer system from Zeiss 
(Jena, Germany) using a Zeiss Observer Z1 microscope, equipped with a Cascade 1 K camera, a monitorized 
X/Y stage, and a Module S incubator with equipment for temperature and CO2 control. During all experiments 
cells were kept in a humidified atmosphere of 5% CO2 in air at 37 °C. Axio Vision Rel. 4.8 software (Zeiss) for 
time-lapse imaging and cell tracking was used. Phase contrast images of cells were taken every 60 min using a × 4 
objective (Achromatic, Zeiss). Cell migration was scored in at least 10 independent experiments per condition. 
The farthest distance of cell migration was calculated from the edge of the sphere. Resulting movies were collected 
and exported as avi files and are shown at 5 frames per second (See Supporting Videos 1–5).
Statistical analysis. Data were analyzed using a one-way ANOVA with treatment as factor (control, harmol, 
harmine, harmaline, THH). Significant results in the ANOVA (p < 0.05) were followed by post-hoc pair-wise test 
(Bonferroni). The SPSS statistical software package (version 20.0) for Windows (Chicago, IL, USA) was used for 
all statistical analyses.
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